MOZ inhibitors (Cancer Therapeutics CRC)

N/A

Report date: 2025/03/20 20:00:06

NME

Base Information

Drug NameMOZ inhibitors (Cancer Therapeutics CRC)

Drug Alias Namemonocytic leukemia zinc finger inhibitors (Cancer Therapeutics CRC)MOZ inhibitors (Cancer Therapeutics CRC/Walter and Eliza Hall Institute of Medical Research)

ClassificationSmall molecules > Heterocyclic drugs

Mechanisms of ActionEnzymes inhibitors

TargetsEnzymes

Therapy Area/IndicationsLeukemia, Myeloid, Acute

Global Approved IndicationsN/A

Approved Indications in ChinaN/A

Original Approved Country/TerritoryN/A

Original Approved DateN/A

Country/TerritoryAustralia and New Zealand

CombinationsNo

Global Highest StatusPending (Preclinical)

Highest Status in ChinaN/A

Originator CompaniesCancer Therapeutics CRC Pty Ltd

China Registration ClassN/A

Develop Information

Active CompaniesN/A

Inactive CompaniesCancer Therapeutics CRC Pty Ltd Walter And Eliza Hall Institute Of Medical Research

Active IndicationsN/A

Inactive IndicationsLeukemia, Myeloid, Acute

Other Information

ATC CodeN/A